10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2019 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2019 10-K (Filed: Feb 12, 2020) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
| Cash flows from operating activities: | |||
| Net income | $ 7,842 | 8,394 | 1,979 |
| Depreciation, amortization and other | 2,206 | 1,946 | 1,955 |
| Stock-based compensation expense | 308 | 311 | 329 |
| Deferred income taxes | (289) | (363) | (1,330) |
| Other items, net | 186 | (386) | (334) |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (504) | (378) | (58) |
| Inventories | (66) | (3) | 133 |
| Other assets | 10 | 35 | (24) |
| Accounts payable | 164 | (143) | 424 |
| Accrued income taxes, net | (585) | (361) | 523 |
| Long-term tax liabilities | (146) | 258 | 6,681 |
| Other liabilities | 396 | 1,214 | 231 |
| Net cash provided by operating activities | 9,150 | 11,296 | 11,177 |
| Cash flows from investing activities: | |||
| Purchases of marketable securities | (9,394) | (18,741) | (33,607) |
| Proceeds from sales of marketable securities | 8,842 | 28,356 | 24,240 |
| Proceeds from maturities of marketable securities | 20,548 | 5,412 | 6,174 |
| Purchases of property, plant and equipment | (618) | (738) | (664) |
| Cash paid for acquisitions, net of cash acquired | (13,617) | 195 | (19) |
| Other | (52) | (145) | (148) |
| Net cash provided by (used in) investing activities | 5,709 | 14,339 | (4,024) |
| Cash flows from financing activities: | |||
| Net proceeds from issuance of debt | 0 | 0 | 4,476 |
| Repayment of debt | (4,514) | (1,121) | (4,405) |
| Repurchases of common stock | (7,702) | (17,794) | (3,160) |
| Dividends paid | (3,509) | (3,507) | (3,365) |
| Withholding taxes arising from shares withheld for share-based payments | (137) | (126) | (191) |
| Other | 95 | 58 | 51 |
| Net cash used in financing activities | (15,767) | (22,490) | (6,594) |
| (Decrease) increase in cash and cash equivalents | (908) | 3,145 | 559 |
| Cash and cash equivalents at beginning of year | 6,945 | 3,800 | |
| Cash and cash equivalents at end of year | 6,037 | 6,945 | 3,800 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2019 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |